Articles by davevbs

FDA Grants Vascular BioSciences Humanitarian Use Device (HUD) Designation to the Endoarterial Biopsy Catheter for Group 1 Pulmonary Arterial Hypertension

2019-09-09 // 0 Comments

GOLETA, USA, 2019-Sep-09 — /EPR Network/ — Vascular Biosciences (VBS) is pleased to announce the receipt of a Humanitarian Use Device (HUD) designation from the U.S. [read full press release…]

Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension

2018-10-22 // 0 Comments

Durham, North Carolina, 2018-Oct-22 — /EPR Network/ — Vascular BioSciences (VBS) is proud to report the award of Phase II STTR grant funding from the [read full press release…]

Vascular BioSciences Awarded Up To $2.3 Million Fast-Track STTR Grant From NHLBI To Develop CAR Peptide For Pulmonary Hypertension

2017-09-11 // 0 Comments

DURHAM, North Carolina, 2017-Sep-11 — /EPR Network/ — Vascular BioSciences announced today it has an award for a Phase I/II Fast-Track STTR grant in collaboration [read full press release…]

Vascular BioSciences Announces Publication of “Assessment of microRNA and gene dysregulaton in pulmonary hypertension by endoarterial biopsy” in the Current Issue of Pulmonary Circulation

2017-05-26 // 0 Comments

Goleta, CA, US, 2017-May-26 — /EPR Network/ — Vascular BioSciences announces publication of “Assessment of microRNA and gene dysregulaton in pulmonary hypertension by endoarterial biopsy” in the [read full press release…]

Vascular BioSciences congratulates VP of Communications, Dr Susana Peinado, Ph.D., on being awarded her Doctorate from UCSB School of Communication

2016-06-07 // 0 Comments

GOLETA, CA, 2016-Jun-07 — /EPR Network/ — Vascular BioSciences announced today that Dr. Susana Peinado, Ph.D., Vice President of Communications at Vascular BioSciences, was awarded a [read full press release…]